Go Pro

EFG International AG Makes New Investment in Danaher Corporation $DHR

Danaher logo with Healthcare background
Image from MarketBeat Media, LLC.

EFG International AG purchased a new stake in shares of Danaher Corporation (NYSE:DHR - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 92,526 shares of the conglomerate's stock, valued at approximately $17,633,000.

Several other institutional investors and hedge funds have also recently made changes to their positions in the company. Sivia Capital Partners LLC increased its position in Danaher by 6.3% during the 2nd quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate's stock valued at $397,000 after purchasing an additional 119 shares during the period. First Trust Advisors LP lifted its position in shares of Danaher by 34.5% in the 2nd quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate's stock worth $10,947,000 after purchasing an additional 14,217 shares during the period. Main Street Financial Solutions LLC boosted its stake in shares of Danaher by 40.2% during the second quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate's stock valued at $610,000 after purchasing an additional 886 shares in the last quarter. Ieq Capital LLC increased its holdings in Danaher by 64.2% during the second quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate's stock valued at $14,957,000 after buying an additional 29,592 shares during the period. Finally, HUB Investment Partners LLC raised its stake in Danaher by 30.7% in the second quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate's stock worth $273,000 after buying an additional 325 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on DHR shares. Citigroup started coverage on Danaher in a report on Tuesday, May 26th. They issued a "buy" rating and a $230.00 price target on the stock. DZ Bank assumed coverage on Danaher in a research note on Wednesday, June 3rd. They issued a "buy" rating and a $210.00 target price on the stock. Wells Fargo & Company decreased their price target on shares of Danaher from $212.00 to $195.00 and set an "equal weight" rating for the company in a research report on Wednesday, July 22nd. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and issued a $240.00 price objective on shares of Danaher in a research report on Wednesday, July 22nd. Finally, Royal Bank Of Canada increased their target price on shares of Danaher from $200.00 to $215.00 and gave the company an "outperform" rating in a research report on Wednesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $228.91.

Read Our Latest Analysis on DHR

Danaher Stock Up 0.3%

DHR stock opened at $215.78 on Wednesday. The company has a market capitalization of $151.69 billion, a P/E ratio of 38.33, a price-to-earnings-growth ratio of 2.68 and a beta of 0.78. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The firm's fifty day simple moving average is $197.17 and its 200-day simple moving average is $192.36. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The business had revenue of $6.26 billion during the quarter, compared to analysts' expectations of $6.12 billion. During the same quarter in the previous year, the firm posted $0.77 EPS. The company's revenue for the quarter was up 5.5% on a year-over-year basis. As a group, equities research analysts forecast that Danaher Corporation will post 8.53 earnings per share for the current year.

About Danaher

(Free Report)

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Featured Articles

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Danaher Right Now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines